<!doctype html><html lang="en-US" data-no-contents-sidebar><head><meta charset="UTF-8"><meta name="viewport" content="width=device-width, initial-scale=1, minimum-scale=1"><title>Articles by Date - Transfeminine Science</title><link rel="preload" href="../assets/images/branding/logo.png" as="image" /><link rel="preload" href="../assets/images/branding/logo-dark.png" as="image" /><link rel="stylesheet" href="../assets/css/vendor/normalize.css"><link rel="stylesheet" href="../assets/css/variables.css"><link rel="stylesheet" href="../assets/css/site-layout.css"><link rel="stylesheet" href="../assets/css/article-content.css"><link rel="stylesheet" href="../assets/css/print.css"><meta name="robots" content="noarchive"><link rel="apple-touch-icon" sizes="180x180" href="../apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png"><link rel="icon" href="../favicon.ico"><link rel="manifest" href="../site.webmanifest"><meta name="msapplication-TileColor" content="#ece5ff"><meta name="theme-color" content="#ffffff"><link type="application/atom+xml" rel="alternate" href="../feed-posts.xml" title="Transfeminine Science" /><link rel="alternate" type="application/atom+xml" title="Articles by Date - Transfeminine Science" href="../feed.xml"><link rel="canonical" href="index.html" /><meta property="og:title" content="Articles by Date" /><meta property="og:image" content="https://transfemscience.org/assets/images/branding/logo-alt.png" /><meta name="twitter:image" content="https://transfemscience.org/assets/images/branding/logo-alt.png" /><meta property="og:url" content="https://transfemscience.org/articles-by-date/" /><meta property="og:locale" content="en_US" /><meta property="og:site_name" content="Transfeminine Science" /><meta property="og:type" content="article" /><meta name="twitter:card" content="summary" /><meta name="publisher" content="Transfeminine Science"><meta name="description" content="Articles by Date - Transfeminine Science" /><meta property="og:description" content="Articles by Date - Transfeminine Science" /> <script type="application/ld+json"> { "@context": "https://schema.org", "name": "Articles by Date", "mainEntityOfPage": "https://transfemscience.org/articles-by-date/", "headline": "Articles by Date", "url": "https://transfemscience.org/articles-by-date/", "isAccessibleForFree": "True", "description": "Articles by Date", "@type": "WebPage", "publisher": { "@type": "Organization", "name": "Transfeminine Science", "url": "https://transfemscience.org", "email": "", "logo": "https://transfemscience.org/assets/images/branding/logo.png" } } </script><script type="application/ld+json"> { "@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://transfemscience.org/" }, { "@type": "ListItem", "position": 2, "name": "Articles", "item": "https://transfemscience.org/articles/" }, { "@type": "ListItem", "position": 3, "name": "Articles by Date" } ] } </script> <script src="../assets/js/script.js"></script></head><body> <svg xmlns="http://www.w3.org/2000/svg" style="display: none;"> <symbol id="svg-link" viewBox="0 0 24 24"><title>Link</title><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="feather feather-link"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path> </svg> </symbol> </svg><div id="header"><div id="header-subcontainer"> <a href="../index.html" id="site-icon-and-title-container"> <span id="site-icon">&nbsp;</span> <span id="site-title" translate="no" class="notranslate"> <span id="site-title-text-xs">TFS</span> <span id="site-title-text-sm">TFSci</span> <span id="site-title-text-md">Transfem Sci</span> <span id="site-title-text-lg">Transfeminine Science</span> </span> </a> <span id="top-links"> <a href="../articles/index.html" class="top-link">Articles</a> <a href="index.html" class="top-link">Latest</a> <a href="../misc/index.html" class="top-link">Misc</a> <a href="../about/index.html" class="top-link">About</a> </span> <span id="top-buttons"> <button id="theme-button" class="top-button" title="Theme (light/dark)"> <svg id="theme-button-light-svg" class="top-button-svg" width="20" height="20" viewBox="0 0 32 32"><path d="M16 12.005a4 4 0 1 1-4 4a4.005 4.005 0 0 1 4-4m0-2a6 6 0 1 0 6 6a6 6 0 0 0-6-6z"></path><path d="M5.394 6.813l1.414-1.415l3.506 3.506L8.9 10.318z"></path><path d="M2 15.005h5v2H2z"></path><path d="M5.394 25.197L8.9 21.691l1.414 1.415l-3.506 3.505z"></path><path d="M15 25.005h2v5h-2z"></path><path d="M21.687 23.106l1.414-1.415l3.506 3.506l-1.414 1.414z"></path><path d="M25 15.005h5v2h-5z"></path><path d="M21.687 8.904l3.506-3.506l1.414 1.415l-3.506 3.505z"></path><path d="M15 2.005h2v5h-2z"></path></svg> <svg id="theme-button-dark-svg" class="top-button-svg" width="20" height="20" viewBox="0 0 32 32"><path d="M13.502 5.414a15.075 15.075 0 0 0 11.594 18.194a11.113 11.113 0 0 1-7.975 3.39c-.138 0-.278.005-.418 0a11.094 11.094 0 0 1-3.2-21.584M14.98 3a1.002 1.002 0 0 0-.175.016a13.096 13.096 0 0 0 1.825 25.981c.164.006.328 0 .49 0a13.072 13.072 0 0 0 10.703-5.555a1.01 1.01 0 0 0-.783-1.565A13.08 13.08 0 0 1 15.89 4.38A1.015 1.015 0 0 0 14.98 3z"></path></svg> </button> <button id="language-button" class="top-button" title="Translate"> <svg class="top-button-svg" xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24"><path d="M12.65 15.67c.14-.36.05-.77-.23-1.05l-2.09-2.06.03-.03c1.74-1.94 2.98-4.17 3.71-6.53h1.94c.54.0.99-.45.99-.99v-.02c0-.54-.45-.99-.99-.99H10V3c0-.55-.45-1-1-1s-1 .45-1 1v1H1.99c-.54.0-.99.45-.99.99.0.55.45.99.99.99h10.18C11.5 7.92 10.44 9.75 9 11.35c-.81-.89-1.49-1.86-2.06-2.88-.16-.29-.45-.47-.78-.47-.69.0-1.13.75-.79 1.35.63 1.13 1.4 2.21 2.3 3.21L3.3 16.87c-.4.39-.4 1.03.0 1.42.39.39 1.02.39 1.42.0L9 14l2.02 2.02c.51.51 1.38.32 1.63-.35zM17.5 10c-.6.0-1.14.37-1.35.94l-3.67 9.8c-.24.61.22 1.26.87 1.26.39.0.74-.24.88-.61l.89-2.39h4.75l.9 2.39c.14.36.49.61.88.61.65.0 1.11-.65.88-1.26l-3.67-9.8c-.22-.57-.76-.94-1.36-.94zm-1.62 7 1.62-4.33L19.12 17h-3.24z"></path></svg> </button> <button id="search-button" class="top-button" title="Search"> <svg version="1.1" class="top-button-svg" width="24" height="24" viewBox="0 0 32 32" xmlns="http://www.w3.org/2000/svg" xmlns:sketch="http://www.bohemiancoding.com/sketch/ns" xmlns:xlink="http://www.w3.org/1999/xlink"><g><path d="M19.4271164,21.4271164 C18.0372495,22.4174803 16.3366522,23 14.5,23 C9.80557939,23 6,19.1944206 6,14.5 C6,9.80557939 9.80557939,6 14.5,6 C19.1944206,6 23,9.80557939 23,14.5 C23,16.3366522 22.4174803,18.0372495 21.4271164,19.4271164 L27.0119176,25.0119176 C27.5621186,25.5621186 27.5575313,26.4424687 27.0117185,26.9882815 L26.9882815,27.0117185 C26.4438648,27.5561352 25.5576204,27.5576204 25.0119176,27.0119176 L19.4271164,21.4271164 L19.4271164,21.4271164 Z M14.5,21 C18.0898511,21 21,18.0898511 21,14.5 C21,10.9101489 18.0898511,8 14.5,8 C10.9101489,8 8,10.9101489 8,14.5 C8,18.0898511 10.9101489,21 14.5,21 L14.5,21 Z"></path></g></svg> </button> <button id="toc-button-mobile" class="top-button" title="Article contents (Ctrl+Shift+L)"> <svg class="top-button-svg" xmlns="http://www.w3.org/2000/svg" version="1.0" width="16" height="16" viewBox="0 0 16 16"><g transform="translate(0,16) scale(0.002536,-0.002540)"><path d="M550 6274 c-81 -17 -207 -79 -282 -139 -110 -87 -202 -230 -238 -371 -20 -76 -20 -122 -20 -2618 0 -2810 -5 -2597 65 -2741 87 -180 227 -304 420 -372 l80 -28 2551 -3 2551 -2 98 25 c253 64 441 251 506 503 19 73 19 137 19 2617 0 2478 0 2544 -19 2617 -51 198 -181 361 -361 451 -53 26 -126 54 -165 62 -103 21 -5105 21 -5205 -1z m5055 -3129 l0 -2440 -2447 -3 -2448 -2 0 2445 0 2445 2448 -2 2447 -3 0 -2440z" /><path d="M1410 4893 c0 -2 0 -158 0 -348 l-1 -346 346 0 346 0 0 346 0 346 -346 2 c-190 1 -345 1 -345 0z" /><path d="M2460 4893 c0 -2 0 -158 0 -348 l-1 -345 1221 0 1221 0 0 345 0 345 -1221 3 c-671 1 -1220 1 -1220 0z" /><path d="M1407 3493 c-1 -1 -1 -157 1 -347 l3 -346 344 0 345 0 0 340 c0 187 0 342 0 345 0 5 -689 13 -693 8z" /><path d="M2457 3493 c-1 -1 -1 -157 1 -347 l3 -346 1219 0 1220 0 0 340 c0 187 -1 342 -2 345 -3 4 -2437 13 -2441 8z" /><path d="M1409 2096 c-2 -2 -3 -160 -1 -350 l3 -346 344 0 344 0 3 346 c2 190 1 348 -1 350 -6 5 -686 5 -692 0z" /><path d="M2459 2096 c-2 -2 -3 -160 -1 -350 l3 -346 1219 0 1219 0 3 346 c2 190 1 348 -1 350 -6 5 -2436 5 -2442 0z" /></g></svg> </button> <button id="menu-button-mobile-menu" class="top-button" title="Menu"> <svg class="top-button-svg" xmlns="http://www.w3.org/2000/svg" width="21" height="21" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"><path d="M 3,12 L 21,12" /><path d="M 3,6 L 21,6" /><path d="M 3,18 L 21,18" /></svg> </button> <button id="hide-persistent-header-button" class="top-button" title="Hide top bar (Ctrl+Shift+H)"> <svg id="hide-persistent-header-button-svg" version="1.1" x="0px" y="0px" width="20px" height="20px" viewBox="0 0 24 24" enable-background="new 0 0 24 24" xml:space="preserve" fill="#5F6368"><path d="M8.59,16.59L13.17,12L8.59,7.41L10,6l6,6l-6,6L8.59,16.59z"></path><path fill="none" d="M0,0h24v24H0V0z"></path></svg> </button> </span></div><div id="mobile-menu"> <span id="top-links-mobile"> <a href="../articles/index.html" class="top-link">Articles</a> <a href="index.html" class="top-link">Latest</a> <a href="../misc/index.html" class="top-link">Misc</a> <a href="../about/index.html" class="top-link">About</a> </span></div></div><button id="restore-persistent-header-button" class="top-button" title="Show top bar (Ctrl+Shift+H)"> <svg id="restore-persistent-header-button-svg" version="1.1" x="0px" y="0px" width="20px" height="20px" viewBox="0 0 24 24" enable-background="new 0 0 24 24" xml:space="preserve" fill="#5F6368"><path d="M8.59,16.59L13.17,12L8.59,7.41L10,6l6,6l-6,6L8.59,16.59z"></path><path fill="none" d="M0,0h24v24H0V0z"></path></svg> </button> <button id="sidebar-button-standalone" class="sidebar-button" title="Article contents (Ctrl+Shift+L)"> <span id="sidebar-button-standalone-icon" class="sidebar-button-icon"> <svg id="sidebar-button-standalone-icon-svg" class="sidebar-button-icon-svg" xmlns="http://www.w3.org/2000/svg" version="1.0" width="16" height="16" viewBox="0 0 16 16"><g transform="translate(0,16) scale(0.002536,-0.002540)"><path d="M550 6274 c-81 -17 -207 -79 -282 -139 -110 -87 -202 -230 -238 -371 -20 -76 -20 -122 -20 -2618 0 -2810 -5 -2597 65 -2741 87 -180 227 -304 420 -372 l80 -28 2551 -3 2551 -2 98 25 c253 64 441 251 506 503 19 73 19 137 19 2617 0 2478 0 2544 -19 2617 -51 198 -181 361 -361 451 -53 26 -126 54 -165 62 -103 21 -5105 21 -5205 -1z m5055 -3129 l0 -2440 -2447 -3 -2448 -2 0 2445 0 2445 2448 -2 2447 -3 0 -2440z" /><path d="M1410 4893 c0 -2 0 -158 0 -348 l-1 -346 346 0 346 0 0 346 0 346 -346 2 c-190 1 -345 1 -345 0z" /><path d="M2460 4893 c0 -2 0 -158 0 -348 l-1 -345 1221 0 1221 0 0 345 0 345 -1221 3 c-671 1 -1220 1 -1220 0z" /><path d="M1407 3493 c-1 -1 -1 -157 1 -347 l3 -346 344 0 345 0 0 340 c0 187 0 342 0 345 0 5 -689 13 -693 8z" /><path d="M2457 3493 c-1 -1 -1 -157 1 -347 l3 -346 1219 0 1220 0 0 340 c0 187 -1 342 -2 345 -3 4 -2437 13 -2441 8z" /><path d="M1409 2096 c-2 -2 -3 -160 -1 -350 l3 -346 344 0 344 0 3 346 c2 190 1 348 -1 350 -6 5 -686 5 -692 0z" /><path d="M2459 2096 c-2 -2 -3 -160 -1 -350 l3 -346 1219 0 1219 0 3 346 c2 190 1 348 -1 350 -6 5 -2436 5 -2442 0z" /></g></svg> </span> </button><div id="mid-section"><div id="sidebar"><div id="sidebar-subcontainer"><div id="sidebar-title-container"> <button id="sidebar-button" class="sidebar-button" title="Article contents (Ctrl+Shift+L)"> <span class="sidebar-button-icon"> <svg class="sidebar-button-icon-svg" xmlns="http://www.w3.org/2000/svg" version="1.0" width="16" height="16" viewBox="0 0 16 16"><g transform="translate(0,16) scale(0.002536,-0.002540)"><path d="M550 6274 c-81 -17 -207 -79 -282 -139 -110 -87 -202 -230 -238 -371 -20 -76 -20 -122 -20 -2618 0 -2810 -5 -2597 65 -2741 87 -180 227 -304 420 -372 l80 -28 2551 -3 2551 -2 98 25 c253 64 441 251 506 503 19 73 19 137 19 2617 0 2478 0 2544 -19 2617 -51 198 -181 361 -361 451 -53 26 -126 54 -165 62 -103 21 -5105 21 -5205 -1z m5055 -3129 l0 -2440 -2447 -3 -2448 -2 0 2445 0 2445 2448 -2 2447 -3 0 -2440z" /><path d="M1410 4893 c0 -2 0 -158 0 -348 l-1 -346 346 0 346 0 0 346 0 346 -346 2 c-190 1 -345 1 -345 0z" /><path d="M2460 4893 c0 -2 0 -158 0 -348 l-1 -345 1221 0 1221 0 0 345 0 345 -1221 3 c-671 1 -1220 1 -1220 0z" /><path d="M1407 3493 c-1 -1 -1 -157 1 -347 l3 -346 344 0 345 0 0 340 c0 187 0 342 0 345 0 5 -689 13 -693 8z" /><path d="M2457 3493 c-1 -1 -1 -157 1 -347 l3 -346 1219 0 1220 0 0 340 c0 187 -1 342 -2 345 -3 4 -2437 13 -2441 8z" /><path d="M1409 2096 c-2 -2 -3 -160 -1 -350 l3 -346 344 0 344 0 3 346 c2 190 1 348 -1 350 -6 5 -686 5 -692 0z" /><path d="M2459 2096 c-2 -2 -3 -160 -1 -350 l3 -346 1219 0 1219 0 3 346 c2 190 1 348 -1 350 -6 5 -2436 5 -2442 0z" /></g></svg> </span> </button> <span id="sidebar-title">Contents</span></div><div id="sidebar-contents"><div class="toc-h1"><a id="heading-0" href="index.html#top" class="toc-link">Top of page</a></div></div></div></div><div id="main-area"><div id="article"><h1 id="articles-by-date-latest-first"> <a href="index.html#articles-by-date-latest-first" aria-labelledby="articles-by-date-latest-first" class="anchor-heading"><svg viewBox="0 0 16 16" aria-hidden="true"><use xlink:href="#svg-link"></use></svg></a> Articles by Date (Latest First)</h1><p>   Filter by author: <a href="../articles-by-author/aly/index.html">Aly</a> | <a href="../articles-by-author/lain/index.html">Lain</a> | <a href="../articles-by-author/sam/index.html">Sam</a> | <a href="../articles-by-author/mitzi/index.html">Mitzi</a></p><ul><li><p><a href="../articles/puberty-blockers/index.html">Puberty Blockers: A Review of GnRH Analogues in Transgender Youth</a> (Mitzi, January 2022)</p></li><li><p><a href="../articles/injectable-e2-simulator-release/index.html">An Interactive Web Simulator for Estradiol Levels with Injectable Estradiol Esters</a> (Aly, July 2021)</p></li><li><p><a href="../articles/injectable-e2-meta-analysis/index.html">An Informal Meta-Analysis of Estradiol Curves with Injectable Estradiol Preparations</a> (Aly, July 2021)</p></li><li><p><a href="../articles/sublingual-e2-transfem/index.html">An Exploration of Sublingual Estradiol as an Alternative to Oral Estradiol in Transfeminine People</a> (Sam, June 2021)</p></li><li><p><a href="../articles/transfem-hormone-guidelines/index.html">Clinical Guidelines with Information on Transfeminine Hormone Therapy</a> (Aly, November 2020)</p></li><li><p><a href="../articles/spiro-visceral-fat/index.html">Spironolactone and Claims About Increased Visceral Fat in Transfeminine People</a> (Aly, October 2020)</p></li><li><p><a href="../articles/estrogens-blood-clots/index.html">Estrogens and Their Influences on Coagulation and Risk of Blood Clots</a> (Aly, October 2020)</p></li><li><p><a href="../articles/shbg-unimportant/index.html">The Interactions of Sex Hormones with Sex Hormone-Binding Globulin and Relevance for Transfeminine Hormone Therapy</a> (Aly, July 2020)</p></li><li><p><a href="../articles/shbg-unimportant-suppl/index.html">Supplement: The Interactions of Sex Hormones with Sex Hormone-Binding Globulin and Relevance for Transfeminine Hormone Therapy</a> (Aly, July 2020)</p></li><li><p><a href="../articles/bica-adoption/index.html">Bicalutamide and its Adoption by the Medical Community for Use in Transfeminine Hormone Therapy</a> (Aly, July 2020)</p></li><li><p><a href="../articles/bone-shape-changes/index.html">On Changes in Bone Shape in Transfeminine Individuals Under Gender-Affirming Hormone Therapy</a> (Lain, May 2020)</p></li><li><p><a href="../articles/hormone-levels-female-puberty/index.html">Hormone Levels During Normal Puberty in Cisgender Girls</a> (Aly, April 2020)</p></li><li><p><a href="../articles/breast-cancer/index.html">Breast Cancer Risk with Hormone Therapy in Transfeminine People</a> (Aly, April 2020)</p></li><li><p><a href="../articles/breast-cancer-suppl/index.html">The Possible Role of a Second X Chromosome in Breast Cancer Risk</a> (Aly, April 2020)</p></li><li><p><a href="../articles/cpa-meningioma/index.html">Recent Developments on Cyproterone Acetate and Meningioma Risk Out of France and Implications for Transfeminine People</a> (Aly, April 2020)</p></li><li><p><a href="../articles/e2-equivalent-doses/index.html">Approximate Comparable Dosages of Estradiol by Different Routes</a> (Aly, April 2020)</p></li><li><p><a href="../articles/progestogens-transfem-excerpts/index.html">Sources/Excerpts: Perspectives and Opinions of Clinicians and Researchers Concerning the Use of Progestogens in Transfeminine Hormone Therapy</a> (Sam, April 2020)</p></li><li><p><a href="../articles/oral-vs-transdermal-e2/index.html">Oral versus Transdermal Estradiol in Feminising Hormone Therapy for Transgender Individuals</a> (Sam, April 2020)</p></li><li><p><a href="../articles/oral-vs-transdermal-e2-suppl/index.html">Sources/Excerpts: Reviews, Cohort Studies and Randomised Controlled Trials Comparing the Feminising Efficacy of Estradiol Administered by Oral and Non-Oral Routes</a> (Sam, April 2020)</p></li><li><p><a href="../articles/pep-cardiovascular-analysis/index.html">Analysis of Cardiovascular and Thromboembolic Toxicity with High Dose Parenteral Polyestradiol Phosphate in the Treatment of Prostate Cancer</a> (Sam, April 2020)</p></li><li><p><a href="../articles/nandrolone/index.html">Nandrolone as a Potential Alternative Androgen with Reduced Androgenic Side Effects for Transfeminine and Transmasculine People</a> (Aly, March 2020)</p></li><li><p><a href="../articles/progestogens-breast-cancer/index.html">Progestogens and Breast Cancer in Transgender Women: A Review and Discussion of Risk</a> (Sam, February 2020)</p></li><li><p><a href="../articles/progestogens-breast-dev/index.html">A Comprehensive Review of the Potential of Progestogens for Enhancing Breast Development in Transfeminine People</a> (Aly, February 2020)</p></li><li><p><a href="../articles/progestogens-sexual-desire/index.html">The Influence of Progesterone and Other Progestogens on Sexual Desire and Function</a> (Aly, January 2020)</p></li><li><p><a href="../articles/serms-transfem/index.html">A Review of Selective Estrogen Receptor Modulators and their Potential for Transfeminine Hormone Therapy</a> (Lain, October 2019)</p></li><li><p><a href="../articles/serms-transfem-suppl/index.html">Sources/Excerpts: A Review of Selective Estrogen Receptor Modulators and their Potential for Transfeminine Hormone Therapy</a> (Lain, October 2019)</p></li><li><p><a href="../articles/hormones-fat-metabolism-suppl/index.html">Sources/Excerpts: On the Impact of Sex Hormones on Fat Metabolism with an Eye Towards Transfeminine Hormone Therapy</a> (Lain, September 2019)</p></li><li><p><a href="../articles/hormones-fat-metabolism/index.html">On the Impact of Sex Hormones on Fat Metabolism with an Eye Towards Transfeminine Hormone Therapy</a> (Lain, September 2019)</p></li><li><p><a href="../articles/endo-system-muscle/index.html">The Relationship Between the Endocrine System and Muscle Mass</a> (Lain, August 2019)</p></li><li><p><a href="../articles/progestogens-early-exposure-breast-dev/index.html">Literature on Early Progestogen Exposure and Breast Development</a> (Aly, July 2019)</p></li><li><p><a href="../articles/cpa-dosage/index.html">Low Doses of Cyproterone Acetate Are Maximally Effective for Testosterone Suppression in Transfeminine People</a> (Aly, July 2019)</p></li><li><p><a href="../articles/high-dose-transdermal-e2/index.html">A Review of Studies on Estradiol Levels and Testosterone Suppression with High-Dose Transdermal Estradiol Gel and Ointment in Cisgender Men with Prostate Cancer</a> (Aly, June 2019)</p></li><li><p><a href="../articles/aqueous-suspensions/index.html">Injectable Aqueous Suspensions of Sex Hormones and How Depot Injectables Work</a> (Aly, June 2019)</p></li><li><p><a href="../articles/nonbinary-transfem-overview/index.html">An Exploration of Possibilities for Hormone Therapy in Non-Binary Transfeminine People</a> (Aly, June 2019)</p></li><li><p><a href="../articles/genital-e2-application/index.html">Genital Application via the Scrotum and Neolabia for Greatly Enhanced Absorption of Transdermal Estradiol in Transfeminine People</a> (Aly, March 2019)</p></li><li><p><a href="../articles/oral-e2-leinung-2018/index.html">Analysis of Estradiol and Testosterone Levels with Oral Estradiol in Transfeminine People Based on Leinung et al. (2018)</a> (Aly, March 2019)</p></li><li><p><a href="../articles/transfem-lactation-literature/index.html">Published Case Reports of Lactation and/or Breastfeeding in Transfeminine People</a> (Aly, March 2019)</p></li><li><p><a href="../articles/sublingual-ev/index.html">Sublingual Administration of Oral Estradiol Valerate Tablets for Transfeminine People</a> (Aly, January 2019)</p></li><li><p><a href="../articles/spiro-testosterone/index.html">A Review of Studies on Spironolactone and Testosterone Suppression in Cisgender Men, Cisgender Women, and Transfeminine People</a> (Aly, December 2018)</p></li><li><p><a href="../articles/buserelin-inexpensive/index.html">Buserelin, a Gonadotropin-Releasing Hormone Agonist, is Inexpensively Available as a Nasal Spray From Online Pharmacies</a> (Aly, August 2018)</p></li><li><p><a href="../articles/oral-p4-low-levels/index.html">Oral Progesterone Achieves Very Low Levels of Progesterone and Has Only Weak Progestogenic Effects</a> (Aly, August 2018)</p></li><li><p><a href="../articles/oral-p4-low-levels-literature/index.html">Sources/Excerpts: Oral Progesterone Achieves Very Low Levels of Progesterone and Has Only Weak Progestogenic Effects</a> (Aly, August 2018)</p></li><li><p><a href="../articles/transfem-intro/index.html">An Introduction to Hormone Therapy for Transfeminine People</a> (Aly, August 2018)</p></li><li><p><a href="../articles/ec508/index.html">EC508 (Estradiol Aminosulfonylbenzoylproline), a Unique and Highly Promising Estradiol Ester and Possible Oral Estradiol Form of the Future</a> (Aly, August 2018)</p></li></ul></div></div><div id="footer"> <span id="footer-subcontainer"> <span id="site-copyright">&copy; 2024 <span translate="no" class="notranslate">Transfeminine Science</span></span> </span></div></div></body></html>